DHI

DR Horton
D

DHI

Arincen52/100B
152.260
USD
-5.38
(-3.41%)
Market Closed
Last updated: · Delayed 15 min
Fair value104.64Plus+46%43Price 152.26158
Q1 FY2027 · Earnings report
EPS estimate 1.34Revenue estimate 6.07B
OverviewFinancialsForecastEarningsDividendsCompany

DR Horton revenue 1992–2026

DR Horton's revenue in Q4 FY2026, the three months to 30 September 2026, was 9.37B USD, down 3.2% on the same quarter a year before. DR Horton's revenue over the last twelve months was 33.04B USD, down 3.5% on the twelve months before. In fiscal year 2026 it was 33.04B USD, down 3.5% on the year before.

Last updated 6 Nov 2026 · Next report 19 Jan 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 202633.04B-3.52%7.36B2.89B
FY202630 Sept 202633.04B-3.52%7.36B2.89B
FY202530 Sept 202534.25B-6.93%8.12B3.59B
FY202430 Sept 202436.80B+3.78%9.54B4.76B
FY202330 Sept 202335.46B+5.92%9.35B4.75B
FY202230 Sept 202233.48B+20.54%10.50B5.86B
FY202130 Sept 202127.77B+36.74%7.88B4.18B
FY202030 Sept 202020.31B+15.45%4.94B2.37B
FY201930 Sept 201917.59B+9.49%3.87B1.62B
FY201830 Sept 201816.07B+14.03%3.67B1.46B
FY201730 Sept 201714.09B+15.90%3.05B1.04B
FY201630 Sept 201612.16B+12.32%2.65B886.30M
FY201530 Sept 201510.82B+34.88%2.29B750.70M
FY201430 Sept 20148.02B+28.21%1.76B533.50M
FY201330 Sept 20136.26B+43.76%1.41B462.70M
FY201230 Sept 20124.35B+19.72%861.60M956.30M
FY201130 Sept 20113.64B-17.35%613.50M71.80M
FY201030 Sept 20104.40B+20.30%772.60M245.10M
FY200930 Sept 20093.66B-44.97%118.90M-545.30M
FY200830 Sept 20086.65B-41.17%-1.64B-2.63B
FY200730 Sept 200711.30B-24.95%811.40M-712.50M
FY200630 Sept 200615.05B+8.57%3.63B1.23B
FY200530 Sept 200513.86B+27.88%3.72B1.47B
FY200430 Sept 200410.84B+24.21%2.64B975.10M
FY200330 Sept 20038.73B+29.52%1.92B625.96M
FY200230 Sept 20026.74B+51.25%1.37B404.69M
FY200130 Sept 20014.46B+21.95%928.37M257.01M
FY200030 Sept 20003.65B+15.76%737.08M191.72M
FY199930 Sept 19993.16B+44.99%616.30M159.80M
FY199830 Sept 19982.18B+159.99%421.10M93.40M
FY199730 Sept 1997837.30M+52.99%156.40M65.00M
FY199630 Sept 1996547.30M+25.13%100.80M46.30M
FY199530 Sept 1995437.40M+11.21%79.70M20.50M
FY199430 Sept 1994393.30M+106.89%68.40M17.70M
FY199330 Sept 1993190.10M+53.18%34.90M8.90M
FY199230 Sept 1992124.10M—24.10M9.20M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

DR Horton revenue growth by segment

Q3 FY2026 against Q3 FY2025

Homebuilding8.69B
+1.2%
Forestar Group407.00M
+4.2%
Rental266.10M
-30.1%
Financial Services220.70M
-3.1%
Eliminations and Other-352.90M
—

DR Horton revenue by segment over time

Homebuilding Forestar Group Rental Financial Services Other Segments Eliminations and Other
Fiscal yearHomebuildingForestar GroupRentalFinancial ServicesOther SegmentsEliminations and Other
FY202531.52B -7.2%1.66B +10.1%1.64B -2.7%841.20M -4.7%— -1.36B
FY202433.96B +7.0%1.51B +5.0%1.69B -35.3%882.50M +10.1%— -1.24B
FY202331.74B -0.6%1.44B -5.4%2.61B +410.7%801.50M +0.8%— -1.13B
FY202231.92B +20.1%1.52B +14.6%510.20M +90.5%795.00M -3.5%— —
FY202126.58B +35.3%1.33B +42.3%267.80M 823.60M +40.8%— —
FY202019.64B +15.4%931.80M +117.6%— 584.90M +32.4%37.90M +16.3%—
FY201917.02B +8.9%428.30M +292.2%— 441.70M +17.7%32.60M —
FY201815.62B +13.7%109.20M — 375.30M +7.4%0.00 —
FY201713.74B +15.8%— — 349.50M +18.2%— —
FY201611.86B +12.3%— — 295.60M +11.5%— —

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about DR Horton's revenue

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.